Completed PHASE4 INTERVENTIONAL 1-arm NCT01725360

Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma

Change of Airway Hyperresponsiveness to Mannitol and Methacholine During Intensified Anti-inflammatory Treatment in Patients With Asthma.

Sponsor: Cantonal Hosptal, Baselland

Conditions Asthma

Interventions montelukast

Updated 6 times since 2017 Last updated: Aug 4, 2017 Started: Jan 31, 2007 Primary completion: Dec 31, 2011 Completion: Jan 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Asthma and is currently completed. Cantonal Hosptal, Baselland leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Sep 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Sep 2017 [monthly]

Completed PHASE4

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cantonal Hosptal, Baselland

Data source: Cantonal Hosptal, Baselland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bern, Switzerland